In the British Medical Journal this week, researchers in Sweden and Norway present the results of a 20-year follow-up of a randomized prostate cancer screening trial. More than 1,490 men in the city of Norrköping, Sweden were invited to be screened for prostate cancer every third year from 1987 to 1996 in order for the researchers to determine if prostate cancer screening reduces prostate cancer-specific mortality.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.